John Stafford Archives

A drug that improves levels of “good” cholesterol may not be beneficial for obese individuals, Vanderbilt researchers have discovered.

It might be possible to generate a “metabolically healthy” state of obesity by targeting signaling pathways that improve insulin sensitivity.

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.